GouveriEKatotomichelakisMGouverisH. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease?Angiology. 2014;65(10):869–876.
2.
BiesselsGJ. Brain MRI correlates of cognitive dysfunction in type 2 diabetes: the needle recovered from the haystack?Diabetes Care. 2013;36(12):3855–3856.
3.
BruceDGDavisWACetrulloV. Clinical impact of the temporal relationship between depression and type 2 diabetes: the Fremantle diabetes study phase II. PLoS One. 2013;8(12):e81254.
4.
GrecoDGambinaFPisciottaM. Clinical characteristics and associated comorbidities in diabetic patients with cranial nerve palsies. J Endocrinol Invest. 2012;35(2):146–149.
5.
PapanasNHeliopoulosIPiperidouH. Simultaneous, painless, homolateral oculomotor and trochlear nerve palsies in a patient with type 2 diabetes mellitus. Neuropathy or brainstem infarction?Acta Diabetol. 2006;43(1):19–21.
6.
WatanabeKHaguraRAkanumaY. Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract. 1990;10(1):19–27.
7.
KeaneJR. Third nerve palsy: analysis of 1400 personally-examined inpatients. Can J Neurol Sci. 2010;37(5):662–670.
SaidG. Focal and multifocal diabetic neuropathies. Arq Neuropsiquiatr. 2007;65(4B):1272–1278.
10.
PessinABMartinsRHPimenta WdeP. Auditory evaluation in patients with type 1 diabetes. Ann Otol Rhinol Laryngol. 2008;117(5):366–370.
11.
GuptaSBawejaPMittalS. Brainstem auditory evoked potential abnormalities in type 2 diabetes mellitus. N Am J Med Sci. 2013;5(1):60–65.
12.
Lerman-GarberICuevas-RamosDValdésS. Sensorineural hearing loss—a common finding in early-onset type 2 diabetes mellitus. Endocr Pract. 2012;18(4):549–557.
13.
DurmusCYetiserSDurmusO. Auditory brainstem evoked responses in insulin-dependent (ID) and non-insulin-dependent (NID) diabetic subjects with normal hearing. Int J Audiol. 2004;43(1):29–33.
TóthFVárkonyiTRovóL. Investigation of auditory brainstem function in diabetic patients. Int Tinnitus J. 2003;9(2):84–86.
16.
VárkonyiTTóthFRovóL. Impairment of the auditory brainstem function in diabetic neuropathy. Diabetes Care. 2002;25(3):631–632.
17.
HeravianJEhyaeiAShoeibiN. Pattern visual evoked potentials in patients with type 2 diabetes mellitus. J Ophthalmic Vis Res. 2012;7(3):225–230.
18.
VárkonyiTTPetőTDégiR. Impairment of visual evoked potentials: an early central manifestation of diabetic neuropathy?Diabetes Care. 2002;25(9):1661–1662.
19.
BrinciottiMNapoliAMitticaA. Cortical evoked potentials in children of diabetic mothers. Exp Diabetes Res. 2011;2011:640535.
20.
ZieglerOGuerciBAlganM. Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control. Diabetes Care. 1994;17(10):1141–1147.
21.
VárkonyiTTBörcsökETóthF. Severity of autonomic and sensory neuropathy and the impairment of visual- and auditory-evoked potentials in type 1 diabetes: is there a relationship?Diabetes Care. 2006;29(10):2325–2326.
22.
LelicDBrockCSimrénM. The brain networks encoding visceral sensation in patients with gastrointestinal symptoms due to diabetic neuropathy. Neurogastroenterol Motil. 2014;26(1):46–58.
23.
GraversenCFrøkjaerJBBrockC. Support vector regression correlates single-sweep evoked brain potentials to gastrointestinal symptoms in diabetes mellitus patients. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:5242–5245.
Reske-NeilsenELundbaekKRafaelsenOJ. Pathological changes in the central and peripheral nervous system of young long-term diabetics: II. Spinal cord and peripheral nerve. Diabetologia. 1968;4(1):34–43.
EatonSHarrisNDRajbhandariSM. Spinal cord involvement in diabetic peripheral neuropathy. Lancet. 2001;358(9275):35–36.
28.
SelvarajahDWilkinsonIDEmeryCJ. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care. 2006;29(12):2664–2669.
29.
SuzukiCOzakiITanosakiM. Peripheral and central conduction abnormalities in diabetes mellitus. Neurology. 2000;54(10):1932–1937.
30.
WilkinsonIDSelvarajahDGreigM. Magnetic resonance imaging of the central nervous system in diabetic neuropathy. Curr Diab Rep. 2013;13(4):509–516.
31.
GandhiRSelvarajahDEmeryCJ. Neurochemical abnormalities within sensory pathways in the brain in diabetic neuropathy. Minutes of the 43rd general assembly of the European association for the study of diabetes. Diabetologia. 2008;51(suppl 1):107. Abstract 244.
32.
SelvarajahDWilkinsonIDEmeryCJ. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia. 2008;51(11):2088–2092.
33.
SelvarajahDWilkinsonIDGandhiR. Microvascular perfusion abnormalities of the thalamus in painful but not painless diabetic polyneuropathy: a clue to the pathogenesis of pain in type 1 diabetes. Diabetes Care. 2011;34(3):718–720.
34.
MelzackR.From the gate to the neuromatrix. Pain. 1999;(suppl 6):S121–S126.
35.
TsengMTChiangMCChaoCC. fMRI evidence of degeneration-induced neuropathic pain in diabetes: enhanced limbic and striatal activations. Hum Brain Mapp. 2013;34(10):2733–2746.
36.
PetrouMPop-BusuiRFoersterBR. Altered excitation–inhibition balance in the brain of patients with diabetic neuropathy. Acad Radiol. 2012;19(5):607–612.
